NASDAQ:FITB - Nasdaq - US3167731005 - Common Stock - Currency: USD
Ebrahim H. Poonawala of B of A Securities revised estimates for FITB after an investor meeting, highlighting management's commitment to shareholder returns.
As Donald Trump's administration nears completion of a proposal to ease big bank rules, they are largely expected to cheer the lower SLR.
The projects will collectively add 265MW of new energy for Indiana.
Fifth Third Bancorp. began forging relationships with crypto companies about five years ago, but held off on major investments until regulation became clearer. That moment has arrived, according to the bank’s head of strategy.
“Great uncertainty doesn’t mean greater certainty of a bad outcome,” says Wei Li, global chief investment strategist at BlackRock, as she explains her firm’s continued risk-on view of markets. (Source: Bloomberg)
Air Force One lands at Hamad International Airport in Doha, Qatar, as US President Donald Trump continues his visit to the Middle East. (Source: Bloomberg)
House Republicans could reach an agreement on the state and local tax deduction as soon as Wednesday, according to Speaker Mike Johnson. Tyler Kendall reports on Bloomberg Television. (Source: Bloomberg)
Mentions: MA
The 150MW Heartwood project in Michigan will begin commercial operations in 2026.
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where Nutex Health Inc. (NASDAQ:NUTX) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a […]
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where agilon health, inc. (NYSE:AGL) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a […]
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where Monopar Therapeutics Inc. (NASDAQ:MNPR) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a […]
NTRS' first-quarter results benefit from increases in NII and non-interest income. Yet, rising costs act as a headwind.